Pilot Test of a Community-based Buprenorphine Treatment Intervention

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CBT4CBT for Office Based Buprenorphine

NCT03580902

Opioid-use Disorder

COMPLETED PHASE1/PHASE2

Onsite Buprenorphine Treatment at Syringe Exchange Programs

NCT03150173

Opiate Addiction

COMPLETED PHASE2

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

NCT03420313

Opioid-use Disorder

UNKNOWN PHASE2

Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release

NCT00367302

Opiate Addiction

COMPLETED PHASE1/PHASE2

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

NCT03616236

Opioid Use

SUSPENDED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Dependence Injection Drug Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-intervention

Participants will be enrolled prior to the implementation of the community-based buprenorphine treatment (CBBT) intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Post-intervention

Participants will be enrolled after implementing the community-based buprenorphine treatment (CBBT) intervention

Group Type EXPERIMENTAL

Community-based buprenorphine treatment (CBBT) intervention

Intervention Type BEHAVIORAL

Community-based buprenorphine treatment (CBBT) intervention consists of three components which are delivered to staff of syringe exchange programs, including: 1) providing buprenorphine education, 2) facilitating access to buprenorphine treatment, and 3) providing support to individuals who initiate buprenorphine treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Community-based buprenorphine treatment (CBBT) intervention

Community-based buprenorphine treatment (CBBT) intervention consists of three components which are delivered to staff of syringe exchange programs, including: 1) providing buprenorphine education, 2) facilitating access to buprenorphine treatment, and 3) providing support to individuals who initiate buprenorphine treatment.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least 18 years old
* English or Spanish fluency
* ever injected drugs
* not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
* clients of our collaborating community-based organization
* interested in buprenorphine treatment